Genome instability footprint under rapamycin and hydroxyurea treatments.

Li, Jing; Stenberg, Simon; Yue, Jia-Xing; Mikhalev, Ekaterina; Thompson, Dawn; Warringer, Jonas; Liti, Gianni

Li, Jing; Stenberg, Simon; Yue, Jia-Xing; Mikhalev, Ekaterina; Thompson, Dawn; Warringer, Jonas; Liti, Gianni.

Afiliación

Li J; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
Stenberg S; Université Côte d'Azur, CNRS, INSERM, IRCAN, Nice, France.
Yue JX; Department of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden.
Mikhalev E; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
Thompson D; Université Côte d'Azur, CNRS, INSERM, IRCAN, Nice, France.
Warringer J; Ginkgo Bioworks, Boston, Massachusetts, United States of America.
Liti G; Ginkgo Bioworks, Boston, Massachusetts, United States of America.

PLoS Genet ; 19(11): e1011012, 2023 Nov.

Article en En | MEDLINE | ID: mdl-37931001

Asunto(s)

Hidroxiurea; Saccharomyces cerevisiae; Humanos; Hidroxiurea/farmacología; Saccharomyces cerevisiae/genética; Sirolimus/farmacología; Mutación; Inestabilidad Genómica/genética; ADN Ribosómico/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Saccharomyces cerevisiae / Hidroxiurea Límite: Humans Idioma: En Revista: PLoS Genet Asunto de la revista: GENETICA Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google